There is one major problem here. No one wants to partner with them. So Money is wasted developing worthless products.
This plug and play stuff is idiotic. Build it and hope they come. If they cannot find development partners, sell the company and salvage something.
My only hope with all this silence is that they are doing podras clinical trials for proof of concept. But I doubt it. Which all leads to the question what in the heck are they doing at that company everyday.
Exactly Samsa...next year is make or break time for IPCI...if Odidi keeps floundering around like a fish out of water and proving unwilling or incapable of securing a partner on rexista or regabatin this stock will undergo a reverse split and more dilutive funding.
And the main reason it's failing is because the scientist CEO doesn't listen to what the market has been screaming at him since the Rexista adcom disaster.
The best thing that could ever happen to IPCI over the next several months is Dr. Odidi stepping aside and bringing in a seasoned CEO to get this company back on track.
But I doubt that ever happens because he thinks he's smarter than everyone who's been telling him what's wrong.
News 
Market Data 
Discover 
